Phylogenetic and genetic analysis of feline immunodeficiency virus gag, pol, and env genes from domestic cats undergoing nucleoside reverse transcriptase inhibitor treatment or treatment-naïve cats in Rio de Janeiro, Brazil

Journal of Virology

Volumn 82, Issue 16, 2008, Pages 7863-7874

  Martins, Angelica N ^a   Medeiros, Sheila O ^a   Simonetti, Jose P ^b   Schatzmayr, Hermann G ^b   Tanuri, Amílcar ^a   Brindeiro, Rodrigo M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; LAMIVUDINE; POL PROTEIN; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CAT; CODON; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; GENETIC ANALYSIS; GENETIC VARIABILITY; IMMUNE DEFICIENCY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; TREATMENT DURATION;

ANIMALS; BRAZIL; CATS; DRUG RESISTANCE, VIRAL; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; GENETIC TECHNIQUES; IMMUNODEFICIENCY VIRUS, FELINE; MALE; PHYLOGENY; REVERSE TRANSCRIPTASE INHIBITORS; VARIATION (GENETICS);

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MIRIDAE;

EID: 49149109845     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00310-08     Document Type: Article

References (51)

1. Arai, M., D. D. Earl, and J. K. Yamamoto. 2002. Is AZT/3TC therapy effective against FIV infection or immunopathogenesis? Vet. Immunol. Immunopathol. 85:189-204.
2. Arion, D., N. Kaushik, S. McCormick, G. Borkow, and M. A. Parniak. 1998. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′- deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37:15908-15917.
3. Bachmann, M. H., C. Mathiason-Dubard, G. H. Learn, A. G. Rodrigo, D. L. Sodora, P. Mazzetti, E. A. Hoover, and J. I. Mullins. 1997. Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J. Virol. 71:4241-4253.
4. Boucher, C. A., E. O'Sullivan, J. W. Mulder, C. Ramautarsing, P. Kellam, G. Darby, J. M. Lange, J. Goudsmit, and B. A. Larder. 1992. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J. Infect. Dis. 165:105-110.
5. Caldas, A. P. F., E. S. Leal, E. F. A. Silva, and A. P. Ravazzolo. 2000. Detecção do provirus da imunodeficiência felina em gatos domésticos pela téenica de reação em cadeia da polimerase. Pesq. Vet. Bras. 20:20-25.
6. Carpenter, M. A., E. W. Brown, D. W. MacDonald, and S. J. O'Brien. 1998. Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat. Virology 251:234-243.
7. Caxito, F. A., F. M. Coelho, M. E. Oliveira, and M. Resende. 2006. Feline immunodeficiency virus subtype B in domestic cats in Minas Gerais, Brazil. Vet. Res. Commun. 30:953-956.
8. Greene, W. K., J. Meers, G. del Fierro, P. R. Carnegie, and W. F. Robinson. 1993. Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats. Arch. Virol. 133:51-62.
9. Gu, Z., Q. Gao, H. Fang, H. Salomon, M. A. Parniak, E. Goldberg, J. Cameron, and M. A. Wainberg. 1994. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′,3′-dideoxycytidine and 2′,3′- dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 38:275-281.
10. Harrigan, P. R., C. Stone, P. Griffin, I. Nájera, S. Bloor, S. Kemp, M. Tisdale, and B. Larder. 2000. Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. J. Infect. Dis. 181:912-920.
11. Hayward, J. J., J. Taylor, and A. G. Rodrigo. 2007. Phylogenetic analysis of feline immunodeficiency virus in feral and companion domestic cats of New Zealand. J. Virol. 81:2999-3004.
12. Hohdatsu, T., H. Hirabayashi, K. Motokawa, and H. Koyama. 1996. Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtypes A, B and D classified on the basis of the env gene V3-V5 sequence. J. Gen. Virol. 77:93-100.
13. Imamichi, T., S. C. Berg, H. Imamichi, J. C. Lopez, J. A. Metcalf, J. Falloon, and H. C. Lane. 2000. Relative replication fitness of a high-level 3′-azido-3′-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr→Gly) at codon 69. J. Virol. 74:10958- 10964.
14. Imamichi, T., T. Sinha, H. Imamichi, Y.-M. Zhang, J. A. Metcalf, J. Falloon, and H. C. Lane. 2000. High-level resistance to 3′-azido- 3′-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1. J. Virol. 74:1023-1028.
15. Inada, G., T. Miyazawa, Y. Inoshima, M. Kohmoto, Y. Ikeda, C. H. Liu, J. A. Lin, T. F. Kuo, and T. Mikami. 1997. Phylogenetic analysis of feline immunodeficiency virus isolated from cats in Taiwan. Arch. Virol. 142:1459-1467.
16. Ishida, T., T. Washizu, K. Toriyabe, S. Motoyoshi, I. Tomoda, and N. C. Pedersen. 1989. Feline immunodeficiency virus infection in cats of Japan. J. Am. Vet. Med. Assoc. 194:221-225.
17. Kakinuma, S., K. Motokawa, T. Hohdatsu, J. K. Yamamoto, H. Koyama, and H. Hashimoto. 1995. Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes. J. Virol. 69:3639-3646.
18. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA 3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.
19. Kuritzkes, D. R. 2007. HIV resistance: frequency, testing, mechanisms. Top. HIV Med. 15:150-154.
20. Lole, K. S., R. C. Bollinger, R. S. Paranjape, D. Gadkari, S. S. Kulkarni, N. G. Novak, R. Ingersoll, H. W. Sheppard, and S. C. Ray. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73:152-160.
21. Margot, N. A., E. Isaacson, I. McGowan, A. K. Cheng, R. T. Schooley, and M. D. Miller. 2002. Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir. AIDS 16:1227-1235.
22. Margot, N. A., E. Isaacson, I. McGowan, A. Cheng, and M. D. Miller. 2003. Extended treatment with tenofovir disoproxil fumarate in treatment-experienced HIV-1-infected patients: genotypic, phenotypic, and rebound analyses. J. Acquir. Immune Defic. Syndr. 33:15-21.
23. Masciari, R., L. Cosco, M. C. Diaco, D. N. Delia, T. Ferraro, T. Raimondi, B. Ruperti, and E. Santandrea. 2002. HIV-1: a case of RT67 deletion in a multi-treated non responder patient. New Microbiol. 25:83-88.
24. Medlin, H. K., Y.-Q. Zhu, K. M. Remington, T. R. Phillips, and T. W. North. 1996. Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2′,3′-dideoxycytidine. Antimicrob. Agents Chemother. 40: 953-957.
25. Miller, V., M. Ait-Khaled, C. Stone, P. Griffin, D. Mesogiti, A. Cutrell, R. Harrigan, S. Staszewski, C. Katlama, G. Pearce, and M. Tisdale. 2000. HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. AIDS 14:163-171.
26. Moraillon, A. 1990. Feline immunodepressive retrovirus infections in France. Vet. Rec. 126:68-69.
27. Nakamura, K., Y. Suzuki, K. Ikeo, Y. Ikeda, E. Sato, N. T. P. Nguyen, T. Gojobori, T. Mikami, and T. Miyazawa. 2003. Phylogenetic analysis of Vietnamese isolates of feline immunodeficiency virus: genetic diversity of subtype C. Arch. Virol. 148:783-791.
28. Pecoraro, M. R., K. Tomonaga, T. Miyazawa, Y. Kawaguchi, S. Sugita, Y. Tohya, C. Kai, M. E. Etcheverrigaray, and T. Mikami. 1996. Genetic diversity of Argentine isolates of feline immunodeficiency virus. J. Gen. Virol. 77:2031-2035.
29. Pistello, M., G. Cammarota, E. Nicoletti, D. Matteucci, M. Curcio, D. Del Mauro, and M. Bendinelli. 1997. Analysis of the genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B. J. Gen. Virol. 78:2247-2257.
30. Posada, D., and K. A. Crandall. 1998. MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817-818.
31. Poss, M., H. A. Ross, S. L. Painter, D. C. Holley, J. A. Terwee, S. Vande-Woude, and A. Rodrigo. 2006. Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase. J. Virol. 80:2728-2737.
32. Reche, A., Jr., M. K. Hagiwara, and S. R. R. Lucas. 1999. Estudo clínico da síndrome de imunodeficiência adquirida em gatos domésticos de São Paulo. Braz. J. Vet. Res. Anim. Sci. 34:152-155.
33. Reggeti, F., and D. Bienzle. 2004. Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada. J. Gen. Virol. 85:1843-1852.
34. Rigby, M. A., E. C. Holmes, M. Pistello, A. Mackay, A. J. Brown, and J. C. Neil. 1993. Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J. Gen. Virol. 74:425-436.
35. Ross, L., M. Johnson, R. G. Ferris, S. A. Short, L. R. Boone, T. E. Melby, R. Lanier, M. Shaefer, and M. St Clair. 2000. Deletions in the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase are observed in HIV-1 isolated from subjects during long-term antiretroviral therapy. J. Hum. Virol. 3:144-149.
36. Savarino, A., M. Pistello, D. D'Ostilio, E. Zabogli, F. Taglia, F. Mancini, S. Ferro, D. Matteucci, L. De Luca, M. L. Barreca, A. Ciervo, A. Chimirri, M. Ciccozzi, and M. Bendinelli. 2007. Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS. Retrovirology 4:79. doi:10.1186/1742-4690-4- 79.
37. Smith, R. A., K. M. Remington, R. M. Lloyd, Jr., R. F. Schinazi, and T. W. North. 1997. A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides. J. Virol. 71:2357-2362.
38. Smith, R. A., K. M. Remington, B. D. Preston, R. F. Schinazi, and T. W. North. 1998. A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-β-2′,3′-dideoxy-3′-thiacytidine and 3′-azido-3′-deoxythymidine. J. Virol. 72:2335-2340.
39. Sodora, D. L., E. G. Shpaer, B. E. Kitchell, S. W. Dow, E. A. Hoover, and J. I. Mullins. 1994. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol. 68:2230-2238.
40. Souza, H. J. M., C. H. Teixeira, and R. Graça. 2002. Estudo epidemiológico de infecções pelo vírus da leucemia e/ou imunodeficiência felina, em gatos domésticos do município do Rio de Janeiro. Clín. Vet. 36:14-21.
41. Steinrigl, A., and D. Klein. 2003. Phylogenetic analysis of feline immunodeficiency virus in Central Europe: a prerequisite for vaccination and molecular diagnostic. J. Gen. Virol. 84:1301-1307.
42. Swofford, D. L., G. J. Olsen, P. J. Waddell, and D. M. Hillis. 1996. Phylogenetic inference, p. 407-514. In D. M. Hillis, C. Moritz, and B. K. Mable (ed.), Molecular systematics. Sinauer, Sunderland, MA.
43. Swofford, D. L. 2003. PAUP*. Phylogenetic analysis using parsimony (*and other methods). Version 4. Sinauer Associates, Sunderland, MA.
44. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
45. Uhl, E. W., T. G. Heaton-Jones, R. Pu, and J. K. Yamamoto. 2002. FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review. Vet. Immunol. Immunopathol. 90:113-132.
46. Winston, A., S. Mandalia, D. Pillay, B. Gazzard, and A. Pozniak. 2002. The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients. AIDS 16:2087-2089.
47. Winters, M. A., R. W. Shafer, R. A. Jellinger, G. Mamtora, T. Gingeras, and T. C. Merigan. 1997. Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years. Antimicrob. Agents Chemother. 41:757-762.
48. Winters, M. A., K. L. Coolley, P. Cheng, Y. A. Girard, H. Hamdan, L. C. Kovari, and T. C. Merigan. 2000. Genotypic, phenotypic, and modeling studies of a deletion in the β3-β4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors. J. Virol. 74:10707-10713.
49. Yamamoto, J. K., R. Pu, E. Sato, and T. Hohdatsu. 2007. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine. AIDS 21:547-563.
50. Zhang, D., A. M. Caliendo, J. J. Eron, K. M. DeVore, J. C. Kaplan, M. S. Hirsch, and R. T. D'Aquila. 1994. Resistance to 2′,3′- dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 38:282-287.
51. Zhu, Y. Q., K. M. Remington, and T. W. North. 1996. Mutants of feline immunodeficiency virus resistant to 2′,3′-dideoxy-2′, 3′-didehydrothymidine. Antimicrob. Agents Chemother. 40:1983-1987.